logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Johannes Uhlig

campus institute data science
H指数:25
被引数:1,801

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Current status and future directions of AI in prostate cancer detection on MRI: a special report from the ESUR prostate MRI working group authors

人工智能在前列腺癌MRI检测中的现状与未来方向：ESUR前列腺MRI工作组报告作者

European Radiology
IF4.7
2026-09-180
OAAI
Renato Cuocolo; Andrea Ponsiglione; Georgios Agrotis; Tristan Barrett; Giorgio Brembilla; Iztok Caglic; Hanna Falińska; Charlie Alexander Hamm; Emanuele Messina; Tobias Penzkofer; Raphaële Renard-Penna; Olivier Rouvière; Luca Russo; Evis Sala; Johannes Uhlig; Anwar R. Padhani; Maarten de Rooij
Prostate MRI quality improvement: a Roadmap from the ESUR Prostate MRI Working Group

前列腺MRI质量改进：ESUR前列腺MRI工作组路线图

European Radiology
IF4.7
2026-03-130
OAAI
Adriano B. Dias; Jelle Barentsz; Clare Allen; Ronaldo Hueb Baroni; Hanna Falińska; Caterina Gaudiano; Rossano Girometti; Rajan T. Gupta; Fredrik Jäderling; Daniel Junker; Guido Matthias Kukuk; Ana Sofia L. Moreira; Vibeke Løgager; Philippe Puech; Andrei S. Purysko; Johannes Uhlig; Stephan Ursprung; Geert Villeirs; Jonathan Richenberg; Francesco Giganti
Prospective validation of the metastatic colon cancer score (mCCS) in patients with RAS wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE

转移性结肠癌评分（mCCS）在RAS野生型转移性结直肠癌患者中的前瞻性验证，这些患者接受了一线帕尼单抗联合FOLFIRI/FOLFOX治疗：非干预性研究VALIDATE的最终结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Marschner, N. W.; Uhlig, J.; Jacobasch, L.; Mueller, L.; Reiser, M.; Schuch, A.; Serrer, L.; de Buhr, R.; Siebenbach, H. U.; Goehler, T.; Schroeder, J. K.; Semsek, D.; Koehler, A.; Stuebs, P.; Potthoff, K. M.
Evaluation of the in fl ammation-based modi fi ed Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving fi rst-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110)
ESMO OPEN
IF8.3
2024-05-012
OAAI
Boukovala, M.; Modest, D. P.; Ricard, I.; von Weikersthal, L. Fischer; Decker, T.; Vehling-Kaiser, U.; Uhlig, J.; Schenk, M.; Freiberg-Richter, J.; Peuser, B.; Denzlinger, C.; Reddemann, C. Peveling Genannt; Graeven, U.; Schuch, G.; Schwaner, I.; Heinrich, K.; Neumann, J.; Jung, A.; Held, S.; Stintzing, S.; Heinemann, V.; Michl, M.
Evaluation of the metastatic colorectal cancer score (mCCS) in predicting outcome for patients with RAS wild type metastatic colorectal cancer (mCRC) treated with first-line (1L) panitumumab (PAN) plus FOLFIRI/FOLFOX: Updated interim results of the non-interventional study VALIDATE
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
OA
Reiser, M.; Uhlig, J.; Jacobasch, L.; Mueller, L.; Schuch, A.; Serrer, L.; de Buhr, R.; Siebenbach, H. U.; Goehler, T.; Schroeder, K.; Semsek, D.; Koehler, A.; Stuebs, P.; Potthoff, K. M.; Marschner, N. W.

研究方向

暂未获取到该数据
J
Joachim Lotz
H 指数:49论文数:377被引数:1.1万
A
Annemarie Uhlig
H 指数:15论文数:109被引数:802
H
Hyun S. Kim
H 指数:50论文数:278被引数:1.0万
A
Ali Seif Amir Hosseini
H 指数:14论文数:104被引数:821
J
Jens Frahm
H 指数:96论文数:681被引数:4.0万
L
Lutz Trojan
H 指数:34论文数:250被引数:5,188
A
Andreas Schuster
H 指数:47论文数:462被引数:9,410
H
Hölger Thiele
H 指数:134论文数:1,814被引数:9.9万
S
Stacey Stein
H 指数:26论文数:154被引数:5,834
T
Thomas Stiermaier
H 指数:40论文数:266被引数:5,269